ResMed Inc.
RMD
$245.73
-$13.29-5.13%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 392.59M | 348.54M | 379.71M | 365.04M | 344.62M |
| Total Depreciation and Amortization | 55.94M | 51.27M | 67.94M | 45.65M | 49.50M |
| Total Amortization of Deferred Charges | 6.39M | 6.40M | 6.34M | 6.26M | 6.40M |
| Total Other Non-Cash Items | 27.12M | 25.86M | 26.02M | 29.43M | 23.00M |
| Change in Net Operating Assets | -142.30M | 25.26M | 58.76M | 132.28M | -114.90M |
| Cash from Operations | 339.75M | 457.32M | 538.77M | 578.66M | 308.62M |
| Capital Expenditure | -28.54M | -42.97M | -30.59M | -20.80M | -20.64M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 0.00 | -522.00K | -138.58M | 0.00 | -670.00K |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -22.40M | -9.09M | 35.45M | -10.99M | -15.38M |
| Cash from Investing | -50.94M | -52.58M | -133.71M | -31.79M | -36.69M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -5.00M | -- | -5.00M | 0.00 | -5.00M |
| Issuance of Common Stock | 29.56M | 8.21M | 30.16M | 9.02M | 26.88M |
| Repurchase of Common Stock | -195.32M | -150.73M | -100.60M | -75.39M | -91.72M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -87.58M | -87.75M | -77.59M | -77.70M | -77.70M |
| Other Financing Activities | -- | -- | -10.86M | 0.00 | 0.00 |
| Cash from Financing | -258.35M | -230.27M | -163.89M | -144.07M | -147.54M |
| Foreign Exchange rate Adjustments | 2.77M | -71.00K | 35.57M | 7.96M | -28.81M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 33.22M | 174.40M | 276.74M | 410.77M | 95.58M |